Long optical path
The narrow barrel and curved walls can create reflections and occluded zones that need to be considered in presentation and imaging.
Container-Specific Test Sets
Develop a cartridge-specific set around barrel optics, piston and seal position, crimp and cap presentation, fill characteristics, device-interface regions, and the intended inspection platform.
Design Inputs
Representative standards start with the product, package, process, defect taxonomy, and intended decision. They do not start with a universal count or a generic defect list.
The narrow barrel and curved walls can create reflections and occluded zones that need to be considered in presentation and imaging.
Piston position, elastomer surfaces, cap, seal, and crimp areas create distinct defect and cosmetic regions.
Pen or injector interfaces may introduce dimensional and functional attributes outside a conventional vial inspection program.
Headspace, bubbles, viscosity, and particle motion may respond differently to the available agitation and rotation method.
Final categories depend on the site's approved risk assessment and inspection scope. The examples below are not a universal required set.
A useful set is more than a collection of defective units. Intended use, traceability, status, handling, storage, change, and retirement should be defined.
These answers distinguish regulatory expectations from site-defined study choices. Project-specific protocols and acceptance criteria remain the customer's responsibility.
Not automatically. The two presentations share some components, but geometry, inspection regions, device interfaces, and handling can differ enough to require a separate representativeness assessment.
At minimum: cartridge configuration, fill volume, product appearance and viscosity, intended inspection method, target defect families, quantity, documentation needs, and timeline.
They can be configured for that purpose, but machine work requires a defined challenge strategy, repeatability expectations, and equipment-specific presentation rather than assuming a manual training set is sufficient.
Source status: Applicable requirements depend on product, market, and intended use. Relevant starting points include FDA's draft guidance on visible particles, EU GMP Annex 1, and current USP chapters <790> and <1790>. FDA's document remains draft guidance; USP <1790> is informational. Confirm current licensed texts and market requirements before approving a protocol.
Share your fill volume, product appearance, viscosity, inspection method, defect categories, documentation needs, and target timeline. The quote form now captures those project inputs directly.